Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for ZNF711_TFAP2A_TFAP2D
Z-value: 1.64
Motif logo
Transcription factors associated with ZNF711_TFAP2A_TFAP2D
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZNF711
|
ENSG00000147180.17 | ZNF711 |
|
TFAP2A
|
ENSG00000137203.15 | TFAP2A |
|
TFAP2D
|
ENSG00000008197.5 | TFAP2D |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZNF711 | hg38_v1_chrX_+_85243983_85243997, hg38_v1_chrX_+_85244032_85244073 | -0.54 | 2.3e-03 | Click! |
| TFAP2D | hg38_v1_chr6_+_50713526_50713526 | -0.49 | 6.2e-03 | Click! |
| TFAP2A | hg38_v1_chr6_-_10415043_10415109, hg38_v1_chr6_-_10412367_10412400 | -0.46 | 1.1e-02 | Click! |
Activity profile of ZNF711_TFAP2A_TFAP2D motif
Sorted Z-values of ZNF711_TFAP2A_TFAP2D motif
Network of associatons between targets according to the STRING database.
First level regulatory network of ZNF711_TFAP2A_TFAP2D
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.6 | 10.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 2.3 | 6.9 | GO:0019427 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
| 1.9 | 5.7 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 1.8 | 14.4 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
| 1.6 | 8.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 1.6 | 4.7 | GO:1903400 | L-arginine transmembrane transport(GO:1903400) |
| 1.5 | 4.5 | GO:0070662 | mast cell proliferation(GO:0070662) |
| 1.5 | 5.8 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
| 1.4 | 8.5 | GO:0035602 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 1.4 | 4.2 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
| 1.4 | 11.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
| 1.4 | 5.5 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 1.4 | 1.4 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
| 1.3 | 9.4 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.3 | 5.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 1.3 | 3.8 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 1.2 | 1.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
| 1.2 | 7.2 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
| 1.2 | 3.6 | GO:1903567 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 1.2 | 37.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 1.2 | 3.5 | GO:0042779 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
| 1.1 | 3.4 | GO:0060003 | copper ion export(GO:0060003) |
| 1.1 | 3.4 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 1.1 | 4.4 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.1 | 3.2 | GO:1903892 | negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 1.1 | 3.2 | GO:0035691 | macrophage migration inhibitory factor signaling pathway(GO:0035691) |
| 1.0 | 3.1 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 1.0 | 3.0 | GO:0072192 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 1.0 | 5.0 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 1.0 | 5.0 | GO:1903904 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
| 1.0 | 3.0 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 1.0 | 3.0 | GO:0071931 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) |
| 1.0 | 2.9 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.9 | 2.8 | GO:0061027 | umbilical cord morphogenesis(GO:0036304) umbilical cord development(GO:0061027) |
| 0.9 | 4.6 | GO:2000691 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.9 | 2.8 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.9 | 6.2 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.9 | 3.5 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.9 | 3.5 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
| 0.9 | 0.9 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.9 | 3.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.9 | 0.9 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.9 | 7.8 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.9 | 5.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.8 | 0.8 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.8 | 3.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.8 | 5.9 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.8 | 2.5 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.8 | 2.5 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.8 | 4.8 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.8 | 3.2 | GO:2000983 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.8 | 8.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.8 | 0.8 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.8 | 8.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.8 | 5.5 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.8 | 2.4 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.8 | 8.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.8 | 3.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.8 | 6.0 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
| 0.7 | 1.5 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 0.7 | 2.2 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.7 | 0.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.7 | 0.7 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 0.7 | 17.1 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.7 | 0.7 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.7 | 2.1 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.7 | 2.1 | GO:1904868 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.7 | 2.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.7 | 2.7 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.7 | 15.0 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 0.7 | 2.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 0.7 | 0.7 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.7 | 18.8 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.7 | 2.0 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 0.7 | 2.0 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.7 | 0.7 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.6 | 2.6 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
| 0.6 | 1.9 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.6 | 4.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.6 | 14.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.6 | 2.5 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.6 | 10.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.6 | 1.9 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.6 | 1.2 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.6 | 0.6 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 0.6 | 1.2 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
| 0.6 | 1.8 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.6 | 1.8 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.6 | 1.7 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.6 | 2.3 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.6 | 2.9 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.6 | 5.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.6 | 3.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.6 | 0.6 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 0.6 | 1.7 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.5 | 2.7 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
| 0.5 | 3.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.5 | 4.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.5 | 3.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.5 | 2.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.5 | 1.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.5 | 3.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.5 | 2.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.5 | 2.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.5 | 1.5 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.5 | 1.5 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
| 0.5 | 2.0 | GO:0046223 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.5 | 1.5 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.5 | 7.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.5 | 1.5 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.5 | 14.0 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.5 | 3.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.5 | 5.0 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.5 | 1.5 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 0.5 | 2.0 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.5 | 4.9 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.5 | 24.8 | GO:0042073 | intraciliary transport(GO:0042073) |
| 0.5 | 5.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.5 | 1.5 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.5 | 0.5 | GO:0072098 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
| 0.5 | 1.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.5 | 0.5 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 0.5 | 5.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.5 | 1.9 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.5 | 0.5 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 0.5 | 1.4 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
| 0.5 | 1.4 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) |
| 0.5 | 1.9 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.5 | 1.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.5 | 2.8 | GO:0019640 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.5 | 1.9 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.5 | 1.4 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.5 | 1.8 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.5 | 1.8 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.5 | 2.7 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
| 0.5 | 1.8 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.5 | 2.3 | GO:0019075 | virus maturation(GO:0019075) |
| 0.5 | 1.4 | GO:0010933 | macrophage tolerance induction(GO:0010931) regulation of macrophage tolerance induction(GO:0010932) positive regulation of macrophage tolerance induction(GO:0010933) |
| 0.4 | 3.6 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.4 | 1.3 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.4 | 0.4 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.4 | 1.8 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.4 | 2.2 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.4 | 1.3 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 0.4 | 3.6 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.4 | 1.8 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.4 | 0.4 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.4 | 2.2 | GO:0015705 | iodide transport(GO:0015705) |
| 0.4 | 1.8 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
| 0.4 | 2.6 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.4 | 1.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.4 | 1.7 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.4 | 2.2 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
| 0.4 | 0.9 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.4 | 2.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.4 | 1.3 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.4 | 1.3 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 0.4 | 1.7 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.4 | 1.3 | GO:0070846 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.4 | 1.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.4 | 2.5 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.4 | 1.3 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.4 | 0.4 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
| 0.4 | 1.7 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 0.4 | 1.7 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.4 | 3.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.4 | 1.2 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
| 0.4 | 0.8 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.4 | 1.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.4 | 2.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.4 | 2.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.4 | 2.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.4 | 1.2 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.4 | 0.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.4 | 1.6 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.4 | 1.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.4 | 3.2 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 0.4 | 1.2 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.4 | 4.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.4 | 0.4 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.4 | 3.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.4 | 3.5 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.4 | 1.6 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.4 | 1.2 | GO:0035638 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
| 0.4 | 3.9 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.4 | 1.2 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.4 | 0.8 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.4 | 7.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.4 | 1.9 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) |
| 0.4 | 1.2 | GO:0061011 | hepatic duct development(GO:0061011) |
| 0.4 | 1.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.4 | 5.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.4 | 3.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.4 | 2.3 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.4 | 0.4 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.4 | 4.5 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 0.4 | 1.9 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.4 | 0.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.4 | 10.1 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.4 | 1.9 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.4 | 2.6 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.4 | 0.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.4 | 1.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.4 | 3.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.4 | 1.1 | GO:1903216 | regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.4 | 5.5 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.4 | 7.7 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.4 | 2.5 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.4 | 1.4 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.4 | 3.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.4 | 2.5 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.4 | 6.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.3 | 0.7 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.3 | 1.0 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.3 | 1.7 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.3 | 0.7 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.3 | 1.7 | GO:0001757 | somite specification(GO:0001757) |
| 0.3 | 1.4 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.3 | 0.7 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 0.3 | 1.4 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.3 | 1.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.3 | 0.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.3 | 1.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.3 | 1.3 | GO:1904980 | positive regulation of endosome organization(GO:1904980) |
| 0.3 | 0.3 | GO:2000397 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.3 | 1.0 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 0.3 | 1.0 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
| 0.3 | 8.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.3 | 1.3 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.3 | 1.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.3 | 0.7 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.3 | 2.0 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.3 | 1.3 | GO:0035261 | external genitalia morphogenesis(GO:0035261) |
| 0.3 | 11.4 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.3 | 1.0 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.3 | 1.0 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.3 | 1.9 | GO:2000580 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.3 | 0.3 | GO:2000232 | regulation of rRNA processing(GO:2000232) |
| 0.3 | 1.3 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 0.3 | 0.3 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.3 | 1.0 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.3 | 2.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.3 | 2.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.3 | 0.6 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.3 | 1.0 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.3 | 2.2 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
| 0.3 | 0.9 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.3 | 0.6 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.3 | 0.9 | GO:1903949 | positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.3 | 0.3 | GO:1900920 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 0.3 | 1.3 | GO:0018032 | protein amidation(GO:0018032) |
| 0.3 | 8.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.3 | 3.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.3 | 2.5 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.3 | 3.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.3 | 3.4 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.3 | 0.9 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.3 | 0.9 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.3 | 1.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.3 | 0.9 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.3 | 0.3 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.3 | 0.3 | GO:1903891 | regulation of ATF6-mediated unfolded protein response(GO:1903891) |
| 0.3 | 0.9 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.3 | 1.2 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.3 | 0.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.3 | 2.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.3 | 1.2 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.3 | 5.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.3 | 0.6 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.3 | 0.9 | GO:0051230 | mitotic spindle disassembly(GO:0051228) spindle disassembly(GO:0051230) |
| 0.3 | 0.6 | GO:1900229 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.3 | 1.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.3 | 0.9 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.3 | 1.2 | GO:0071422 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.3 | 2.6 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.3 | 0.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
| 0.3 | 2.0 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.3 | 0.9 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.3 | 0.3 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.3 | 1.7 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.3 | 0.3 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.3 | 1.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.3 | 2.3 | GO:0044782 | cilium organization(GO:0044782) |
| 0.3 | 0.6 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.3 | 0.6 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.3 | 1.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.3 | 0.6 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.3 | 1.4 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.3 | 1.1 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.3 | 1.4 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.3 | 0.8 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.3 | 0.6 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.3 | 0.3 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
| 0.3 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
| 0.3 | 0.8 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.3 | 2.5 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.3 | 0.8 | GO:1903937 | response to acrylamide(GO:1903937) |
| 0.3 | 0.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.3 | 0.5 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.3 | 1.6 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.3 | 0.3 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
| 0.3 | 1.4 | GO:0034486 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
| 0.3 | 4.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.3 | 1.9 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.3 | 0.5 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
| 0.3 | 2.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.3 | 4.3 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
| 0.3 | 0.5 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.3 | 0.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.3 | 1.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.3 | 1.3 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.3 | 0.8 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
| 0.3 | 1.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.3 | 0.8 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.3 | 2.1 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.3 | 0.8 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.3 | 6.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.3 | 4.4 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.3 | 1.0 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 0.3 | 1.0 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.3 | 0.8 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.3 | 3.6 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
| 0.3 | 1.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.3 | 3.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.3 | 0.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.3 | 1.5 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.3 | 3.5 | GO:0060180 | female mating behavior(GO:0060180) |
| 0.3 | 0.5 | GO:0070476 | RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.3 | 5.3 | GO:0097034 | mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.3 | 0.8 | GO:1902996 | regulation of neurofibrillary tangle assembly(GO:1902996) |
| 0.3 | 3.8 | GO:0032310 | prostaglandin secretion(GO:0032310) |
| 0.3 | 1.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.2 | 2.7 | GO:0006999 | nuclear pore organization(GO:0006999) |
| 0.2 | 2.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 | 0.5 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.2 | 1.0 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.2 | 0.7 | GO:0034031 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.2 | 6.2 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.2 | 0.5 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.2 | 0.7 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.2 | 1.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 | 1.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 | 1.2 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 0.2 | 0.7 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.2 | 1.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.2 | 0.7 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.2 | 0.7 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.2 | 2.9 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.2 | 0.7 | GO:0061569 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.2 | 3.4 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.2 | 2.9 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.2 | 1.0 | GO:0052148 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 0.2 | 0.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.2 | 0.5 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.2 | 1.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.2 | 0.7 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.2 | 1.2 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.2 | 0.7 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.2 | 0.7 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.2 | 1.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.2 | 5.6 | GO:0070293 | renal absorption(GO:0070293) |
| 0.2 | 3.0 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.2 | 0.7 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.2 | 1.2 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.2 | 0.9 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.2 | 1.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.2 | 1.1 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.2 | 1.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
| 0.2 | 0.9 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.2 | 1.8 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 0.7 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.2 | 0.5 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.2 | 0.7 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.2 | 0.7 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
| 0.2 | 1.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.2 | 0.9 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.2 | 2.4 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
| 0.2 | 1.3 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.2 | 2.8 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.2 | 0.7 | GO:0036233 | glycine import(GO:0036233) |
| 0.2 | 0.9 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.2 | 0.7 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.2 | 0.2 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.2 | 0.7 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 0.2 | 6.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.2 | 2.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.2 | 0.6 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.2 | 0.6 | GO:0030242 | pexophagy(GO:0030242) |
| 0.2 | 0.4 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.2 | 1.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.2 | 0.4 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.2 | 0.4 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.2 | 2.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
| 0.2 | 1.1 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.2 | 1.5 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.2 | 1.1 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.2 | 2.1 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 | 0.4 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.2 | 1.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 | 1.1 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.2 | 1.1 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
| 0.2 | 2.3 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.2 | 1.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.2 | 0.2 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
| 0.2 | 2.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.2 | 1.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.2 | 0.8 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.2 | 1.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 | 1.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.2 | 1.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.2 | 0.6 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
| 0.2 | 0.8 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.2 | 3.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 | 0.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.2 | 1.4 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 | 1.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 | 0.6 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.2 | 0.6 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.2 | 1.4 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.2 | 0.4 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.2 | 0.6 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.2 | 0.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.2 | 0.6 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.2 | 7.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 | 2.2 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.2 | 1.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.2 | 1.6 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.2 | 0.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.2 | 0.8 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.2 | 1.4 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.2 | 1.4 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.2 | 0.6 | GO:0071486 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) retinal cell apoptotic process(GO:1990009) |
| 0.2 | 0.8 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
| 0.2 | 0.8 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.2 | 2.1 | GO:2000791 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.2 | 0.2 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
| 0.2 | 1.7 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.2 | 1.0 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 | 1.7 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.2 | 1.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.2 | 2.7 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.2 | 1.3 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.2 | 1.0 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 | 1.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 | 7.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.2 | 0.9 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.2 | 2.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.2 | 0.9 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.2 | 0.2 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
| 0.2 | 0.2 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 | 4.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.2 | 0.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.2 | 0.4 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.2 | 0.6 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.2 | 1.3 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.2 | 2.0 | GO:0036302 | atrioventricular canal development(GO:0036302) |
| 0.2 | 0.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.2 | 1.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.2 | 0.5 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.2 | 1.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.2 | 0.7 | GO:1905206 | positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 0.2 | 4.7 | GO:0097502 | mannosylation(GO:0097502) |
| 0.2 | 0.4 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.2 | 0.7 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 | 1.4 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 0.2 | 0.4 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
| 0.2 | 1.6 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.2 | 1.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.2 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.2 | 1.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.2 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.2 | 0.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 | 1.2 | GO:0015677 | copper ion import(GO:0015677) |
| 0.2 | 2.1 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.2 | 1.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 | 0.3 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
| 0.2 | 1.6 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.2 | 0.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.2 | 0.5 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 0.2 | 0.7 | GO:0043366 | beta selection(GO:0043366) |
| 0.2 | 0.2 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
| 0.2 | 0.5 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.2 | 0.7 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.2 | 2.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.2 | 1.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.2 | 0.9 | GO:0030070 | insulin processing(GO:0030070) |
| 0.2 | 0.2 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.2 | 1.7 | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
| 0.2 | 0.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.2 | 1.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 | 1.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.2 | 0.5 | GO:0019483 | beta-alanine biosynthetic process(GO:0019483) |
| 0.2 | 1.0 | GO:0035549 | positive regulation of interferon-beta secretion(GO:0035549) |
| 0.2 | 0.8 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
| 0.2 | 0.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.2 | 3.5 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.2 | 0.8 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.2 | 0.5 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.2 | 2.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.2 | 0.3 | GO:0000964 | mitochondrial RNA 5'-end processing(GO:0000964) |
| 0.2 | 0.5 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.2 | 0.2 | GO:0097694 | regulation of telomere maintenance via semi-conservative replication(GO:0032213) negative regulation of telomere maintenance via semi-conservative replication(GO:0032214) establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 0.2 | 1.3 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.2 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 | 0.5 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.2 | 0.3 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
| 0.2 | 1.0 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.2 | 1.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.2 | 0.6 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.2 | 0.5 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.2 | 0.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.2 | 1.3 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.2 | 0.3 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.2 | 0.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 | 1.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.2 | 2.0 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.2 | 0.9 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.2 | 1.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.2 | 0.8 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.2 | 0.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.2 | 1.2 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.2 | 0.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.2 | 4.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.2 | 0.8 | GO:2001295 | malonyl-CoA metabolic process(GO:2001293) malonyl-CoA biosynthetic process(GO:2001295) |
| 0.2 | 1.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.2 | 0.3 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
| 0.2 | 9.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.2 | 0.9 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 | 1.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.2 | 1.5 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 0.7 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.1 | 0.6 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 0.1 | 0.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
| 0.1 | 0.6 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 | 0.9 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.1 | 0.6 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 | 0.4 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.1 | 0.4 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 | 3.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 | 1.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.1 | 0.1 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.1 | 0.7 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.1 | 2.8 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.1 | 1.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 0.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.1 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 | 0.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.1 | 0.4 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 | 0.6 | GO:0060509 | Type I pneumocyte differentiation(GO:0060509) |
| 0.1 | 1.6 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.1 | 0.6 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 | 4.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.1 | 0.3 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.1 | 0.3 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 0.1 | 1.4 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 | 0.6 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.1 | 1.5 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 | 0.4 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.1 | 0.1 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
| 0.1 | 1.8 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 | 1.5 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.1 | 0.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.1 | 0.4 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
| 0.1 | 1.9 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.1 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.1 | 0.1 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.1 | 2.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 0.4 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.1 | 0.1 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.1 | 0.3 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 0.4 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.1 | 0.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.1 | 0.8 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 1.1 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 | 0.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.1 | 1.5 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 | 0.1 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.1 | 0.7 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 | 1.1 | GO:0006531 | aspartate metabolic process(GO:0006531) |
| 0.1 | 0.5 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 0.1 | 0.4 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.1 | 1.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.1 | 0.4 | GO:0021678 | third ventricle development(GO:0021678) |
| 0.1 | 0.1 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.1 | 9.2 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.1 | 1.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 1.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.1 | 0.8 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 | 1.0 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 | 2.0 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.1 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.1 | 0.6 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 | 1.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.1 | 3.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 | 0.9 | GO:0007379 | segment specification(GO:0007379) |
| 0.1 | 0.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.1 | 0.3 | GO:1903352 | L-ornithine transmembrane transport(GO:1903352) |
| 0.1 | 0.5 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.1 | 0.4 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.1 | 0.3 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.1 | 0.4 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 | 0.5 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
| 0.1 | 0.3 | GO:0002877 | acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.1 | 0.4 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.1 | 10.2 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 2.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.1 | 0.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
| 0.1 | 23.4 | GO:0060271 | cilium morphogenesis(GO:0060271) |
| 0.1 | 2.1 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.1 | 2.6 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 | 0.4 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 | 2.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.1 | 2.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.2 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
| 0.1 | 0.5 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.1 | 1.0 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.1 | 6.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 | 1.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.1 | 1.0 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.1 | 0.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 0.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.1 | 0.5 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 0.1 | 0.1 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.1 | 0.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 1.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 | 0.6 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.1 | 0.2 | GO:1900145 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
| 0.1 | 0.5 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.1 | 0.1 | GO:2000426 | negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.1 | 0.9 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
| 0.1 | 0.1 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.1 | 0.4 | GO:0019878 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 0.1 | 1.3 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.1 | 0.3 | GO:0003341 | cilium movement(GO:0003341) |
| 0.1 | 0.8 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.1 | 0.8 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.1 | 0.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.1 | 0.3 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.1 | 0.3 | GO:0042335 | cuticle development(GO:0042335) |
| 0.1 | 0.6 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.1 | 0.3 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.1 | 0.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.1 | 2.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 0.2 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.1 | 0.3 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.1 | 2.0 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.1 | 0.5 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.1 | 0.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 | 3.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.1 | 1.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 0.7 | GO:0032328 | alanine transport(GO:0032328) |
| 0.1 | 0.4 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.1 | 0.3 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.1 | 1.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.1 | 0.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.1 | 1.9 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.1 | 0.6 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.1 | 0.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.1 | 0.7 | GO:0051589 | negative regulation of neurotransmitter transport(GO:0051589) |
| 0.1 | 0.2 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 0.1 | 0.2 | GO:2000570 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.1 | 1.4 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 0.4 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.1 | 1.2 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 | 1.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 | 0.4 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.1 | 0.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 | 0.1 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.1 | 0.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 | 0.8 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 1.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 | 1.0 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.1 | 0.3 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.1 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.1 | 0.3 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.1 | 0.6 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.1 | 0.7 | GO:0032439 | endosome localization(GO:0032439) |
| 0.1 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.1 | 1.0 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
| 0.1 | 3.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 | 0.2 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.1 | 0.4 | GO:0051572 | negative regulation of histone H3-K36 methylation(GO:0000415) negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.1 | 1.1 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.1 | 2.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 | 0.2 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 0.1 | 0.7 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 | 0.1 | GO:0051795 | positive regulation of catagen(GO:0051795) |
| 0.1 | 0.6 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
| 0.1 | 2.4 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.1 | 1.6 | GO:0001510 | RNA methylation(GO:0001510) |
| 0.1 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.1 | 1.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 0.3 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.1 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 | 1.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 | 0.3 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.1 | 1.4 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 1.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.1 | 2.7 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.1 | 3.0 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
| 0.1 | 0.4 | GO:0071027 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 | 0.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 0.1 | 1.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.1 | 0.4 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 | 0.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 | 0.6 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.1 | 0.1 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
| 0.1 | 0.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 0.1 | 0.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.1 | 0.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
| 0.1 | 0.3 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.1 | 0.3 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.1 | 0.2 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
| 0.1 | 1.0 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 1.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.1 | 0.5 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.1 | 0.2 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 0.1 | 0.5 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 | 1.7 | GO:0072189 | ureter development(GO:0072189) |
| 0.1 | 1.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 0.2 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
| 0.1 | 0.2 | GO:0006311 | meiotic gene conversion(GO:0006311) |
| 0.1 | 0.1 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.1 | 0.3 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.1 | 2.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.1 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.1 | 0.3 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.1 | 1.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 0.8 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.1 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 2.9 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
| 0.1 | 0.1 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.1 | 1.3 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.1 | 0.3 | GO:0021997 | neural plate axis specification(GO:0021997) |
| 0.1 | 2.3 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
| 0.1 | 0.4 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
| 0.1 | 0.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.1 | 0.7 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.1 | 0.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.1 | 0.3 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.1 | 0.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) negative regulation of immunological synapse formation(GO:2000521) |
| 0.1 | 2.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 0.4 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 | 7.3 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
| 0.1 | 1.2 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 | 0.3 | GO:0070893 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.1 | 0.4 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 0.1 | 7.5 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 | 2.4 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.1 | 5.6 | GO:0022900 | electron transport chain(GO:0022900) |
| 0.1 | 0.3 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.1 | 1.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.1 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 | 0.8 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.1 | 0.9 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
| 0.1 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.1 | 1.5 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
| 0.1 | 0.6 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
| 0.1 | 2.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.1 | 1.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.1 | 0.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.1 | 0.2 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.1 | 0.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.2 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.1 | 0.1 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
| 0.1 | 0.2 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
| 0.1 | 0.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 | 2.9 | GO:0072348 | sulfur compound transport(GO:0072348) |
| 0.1 | 0.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 0.8 | GO:0033572 | transferrin transport(GO:0033572) |
| 0.1 | 0.9 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 | 1.1 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.1 | 0.1 | GO:0072054 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.1 | 0.4 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 | 0.5 | GO:0015791 | polyol transport(GO:0015791) glycerol transport(GO:0015793) |
| 0.1 | 0.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 1.5 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.1 | 0.1 | GO:1902232 | regulation of positive thymic T cell selection(GO:1902232) |
| 0.1 | 0.1 | GO:0060995 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.1 | 1.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.3 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.1 | 0.8 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 | 0.8 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.6 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.1 | 0.2 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 | 0.7 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.1 | 0.5 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.1 | 0.5 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.1 | 0.6 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 | 0.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
| 0.1 | 1.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 | 0.4 | GO:0032902 | nerve growth factor production(GO:0032902) |
| 0.1 | 0.4 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.1 | 0.4 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.1 | 3.6 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.1 | 0.1 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
| 0.1 | 0.9 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
| 0.1 | 0.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.1 | 1.2 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 | 2.6 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.1 | 0.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 | 0.3 | GO:1904588 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.1 | 0.3 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 | 0.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 0.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.1 | 0.3 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.1 | 0.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.1 | 0.4 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 0.6 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.1 | 1.1 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 | 0.3 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.1 | 0.5 | GO:0035933 | glucocorticoid secretion(GO:0035933) |
| 0.1 | 0.6 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.1 | 0.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 | 0.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 0.1 | 0.2 | GO:0034661 | ncRNA catabolic process(GO:0034661) |
| 0.1 | 0.6 | GO:0015870 | acetylcholine transport(GO:0015870) |
| 0.1 | 0.3 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.1 | 2.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.1 | 0.2 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
| 0.1 | 1.0 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 0.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 1.1 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.1 | 0.8 | GO:0015866 | ADP transport(GO:0015866) |
| 0.1 | 0.5 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 0.1 | 0.3 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 | 0.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 | 0.8 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.1 | 0.5 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.1 | 0.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 0.1 | GO:1902603 | carnitine transmembrane transport(GO:1902603) |
| 0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 | 0.2 | GO:1901389 | regulation of transforming growth factor beta activation(GO:1901388) negative regulation of transforming growth factor beta activation(GO:1901389) |
| 0.1 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 0.4 | GO:0032472 | Golgi calcium ion homeostasis(GO:0032468) Golgi calcium ion transport(GO:0032472) |
| 0.1 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.1 | 0.3 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.1 | 0.4 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.1 | 0.2 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 | 0.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.1 | 0.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.1 | 0.3 | GO:0021781 | glial cell fate commitment(GO:0021781) |
| 0.1 | 0.4 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 | 0.9 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 | 0.2 | GO:0021691 | cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.1 | 0.1 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 | 1.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 | 0.2 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.1 | 3.5 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 | 0.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 0.2 | GO:1904799 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.1 | 1.4 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 0.3 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
| 0.1 | 0.3 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 | 0.7 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.1 | 0.4 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.1 | 0.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.1 | 0.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 | 0.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.1 | 3.7 | GO:0006885 | regulation of pH(GO:0006885) |
| 0.1 | 0.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.1 | 0.7 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.1 | 0.2 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 1.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 0.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.1 | 0.3 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.1 | 0.6 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.1 | 0.2 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.1 | 0.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 | 3.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 0.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 0.1 | 0.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.1 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
| 0.1 | 0.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 | 0.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 | 0.1 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
| 0.1 | 0.2 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.1 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.1 | 0.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 3.7 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.1 | 0.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 | 0.4 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.1 | 0.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.1 | 0.2 | GO:1904353 | regulation of telomere capping(GO:1904353) |
| 0.1 | 1.1 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.1 | 0.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.1 | 0.2 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 0.1 | 0.1 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.1 | 0.7 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
| 0.1 | 1.1 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 | 0.7 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 | 0.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.1 | 1.6 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 0.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.1 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.1 | 0.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.0 | 0.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.0 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.0 | 1.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.0 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.0 | 0.4 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
| 0.0 | 0.7 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 | 0.2 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
| 0.0 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 | 0.0 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 0.0 | 1.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.0 | 0.8 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.0 | 0.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.0 | 0.8 | GO:0070977 | bone maturation(GO:0070977) |
| 0.0 | 5.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 0.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.0 | 0.0 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.0 | 0.1 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.0 | 0.1 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
| 0.0 | 1.6 | GO:0000266 | mitochondrial fission(GO:0000266) |
| 0.0 | 0.2 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.0 | 0.4 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 0.1 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.0 | 0.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.0 | 0.7 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
| 0.0 | 0.1 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
| 0.0 | 0.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.0 | 0.3 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.0 | 0.0 | GO:0003174 | mitral valve development(GO:0003174) |
| 0.0 | 0.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.0 | 0.2 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.0 | 0.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.0 | 0.4 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.0 | 1.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.1 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.0 | 0.0 | GO:0019376 | galactolipid catabolic process(GO:0019376) |
| 0.0 | 0.1 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.0 | 0.4 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 1.5 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.0 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.0 | 0.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.0 | 0.2 | GO:0001878 | response to yeast(GO:0001878) |
| 0.0 | 0.1 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.0 | 0.0 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.0 | 0.5 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 | 0.1 | GO:0002035 | brain renin-angiotensin system(GO:0002035) angiotensin-mediated drinking behavior(GO:0003051) |
| 0.0 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.0 | 0.1 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 biosynthetic process(GO:0042819) |
| 0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.0 | 0.1 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.0 | 0.1 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.0 | 0.6 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.0 | 0.1 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.0 | 0.6 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 | 0.9 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 | 0.2 | GO:0042701 | progesterone secretion(GO:0042701) |
| 0.0 | 0.3 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.0 | 0.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.0 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.0 | 0.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
| 0.0 | 0.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.0 | 0.1 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.0 | 1.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 | 0.1 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 | 0.4 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.0 | 0.8 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.0 | 0.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
| 0.0 | 1.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.0 | 0.5 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
| 0.0 | 0.2 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.0 | 0.1 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.0 | 1.3 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
| 0.0 | 0.5 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.0 | 0.5 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 | 0.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 | 0.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.0 | 0.1 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.0 | 0.0 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
| 0.0 | 0.3 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.0 | 0.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 | 0.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 | 0.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.0 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.0 | 0.0 | GO:0033206 | meiotic cytokinesis(GO:0033206) polar body extrusion after meiotic divisions(GO:0040038) |
| 0.0 | 0.2 | GO:0072710 | response to hydroxyurea(GO:0072710) |
| 0.0 | 0.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 | 0.0 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.0 | 0.0 | GO:0039019 | pronephric nephron development(GO:0039019) |
| 0.0 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.0 | 0.4 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.4 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 | 0.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
| 0.0 | 0.1 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
| 0.0 | 6.6 | GO:0000209 | protein polyubiquitination(GO:0000209) |
| 0.0 | 0.7 | GO:0007405 | neuroblast proliferation(GO:0007405) |
| 0.0 | 0.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.0 | 0.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.0 | 0.0 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 0.0 | 0.0 | GO:0048664 | neuron fate determination(GO:0048664) |
| 0.0 | 0.1 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.0 | 0.4 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.0 | 0.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.0 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.0 | 0.4 | GO:0060119 | inner ear receptor cell development(GO:0060119) |
| 0.0 | 1.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 | 0.9 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.0 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.1 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.0 | 0.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 | 0.2 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 | 0.1 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.0 | 0.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 | 0.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
| 0.0 | 0.2 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.0 | 0.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 | 0.0 | GO:0014854 | response to inactivity(GO:0014854) |
| 0.0 | 0.0 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.0 | 0.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 0.0 | 0.2 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.0 | 0.4 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
| 0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 | 0.1 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
| 0.0 | 0.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 | 0.1 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.0 | 0.0 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.0 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 | 0.0 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.0 | 0.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.0 | 0.1 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.0 | 0.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 | 0.0 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.0 | 0.0 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
| 0.0 | 0.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 | 0.0 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.0 | 0.1 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
| 0.0 | 0.1 | GO:0099624 | atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.0 | 0.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 0.0 | 0.0 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 0.0 | 0.1 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.0 | 0.0 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.0 | 0.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.0 | 0.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.0 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 9.0 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 1.4 | 4.3 | GO:0070701 | mucus layer(GO:0070701) |
| 1.4 | 6.8 | GO:0072534 | perineuronal net(GO:0072534) |
| 1.2 | 3.7 | GO:0001534 | radial spoke(GO:0001534) |
| 1.2 | 7.0 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 1.1 | 8.0 | GO:0002177 | manchette(GO:0002177) |
| 1.1 | 4.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 1.0 | 5.0 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 1.0 | 4.0 | GO:0097196 | Shu complex(GO:0097196) |
| 1.0 | 22.8 | GO:0036038 | MKS complex(GO:0036038) |
| 1.0 | 10.9 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.9 | 0.9 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.8 | 8.3 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.8 | 2.5 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
| 0.8 | 6.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.8 | 12.8 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.8 | 5.5 | GO:0098536 | deuterosome(GO:0098536) |
| 0.8 | 10.5 | GO:0034464 | BBSome(GO:0034464) |
| 0.7 | 2.2 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.7 | 2.9 | GO:0044307 | dendritic branch(GO:0044307) |
| 0.7 | 4.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.6 | 5.8 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.6 | 1.9 | GO:0060987 | lipid tube(GO:0060987) |
| 0.6 | 7.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.6 | 2.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.6 | 5.2 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.6 | 1.7 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.5 | 10.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.5 | 2.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.5 | 1.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.5 | 2.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.5 | 8.1 | GO:0097433 | dense body(GO:0097433) |
| 0.5 | 1.6 | GO:0044753 | amphisome(GO:0044753) |
| 0.5 | 3.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.5 | 2.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.5 | 4.8 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.5 | 1.4 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.5 | 2.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.5 | 1.4 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.5 | 1.4 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.4 | 1.3 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.4 | 3.6 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 0.4 | 4.4 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.4 | 4.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.4 | 10.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.4 | 1.2 | GO:0030689 | Noc complex(GO:0030689) |
| 0.4 | 12.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.4 | 1.2 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.4 | 4.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.4 | 4.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.4 | 2.4 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.4 | 3.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.4 | 3.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.4 | 1.6 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.4 | 1.2 | GO:0033167 | ARC complex(GO:0033167) |
| 0.4 | 1.9 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.4 | 1.5 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.4 | 9.7 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.4 | 4.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.4 | 1.1 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.4 | 1.8 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.4 | 2.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.3 | 1.7 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.3 | 1.4 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 0.3 | 1.0 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.3 | 0.7 | GO:0030849 | autosome(GO:0030849) |
| 0.3 | 1.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.3 | 1.0 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.3 | 7.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.3 | 5.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.3 | 1.0 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.3 | 1.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.3 | 1.5 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.3 | 0.9 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.3 | 4.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.3 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.3 | 2.4 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.3 | 26.3 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.3 | 1.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.3 | 3.6 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.3 | 0.9 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.3 | 1.2 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.3 | 4.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.3 | 0.6 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.3 | 1.2 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.3 | 2.0 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.3 | 3.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.3 | 0.8 | GO:0032116 | SMC loading complex(GO:0032116) |
| 0.3 | 5.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.3 | 2.0 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.3 | 1.4 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.3 | 3.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.3 | 2.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.3 | 21.7 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.3 | 0.8 | GO:0008623 | CHRAC(GO:0008623) |
| 0.3 | 5.0 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.3 | 1.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.3 | 7.5 | GO:0031094 | platelet dense tubular network(GO:0031094) |
| 0.3 | 1.3 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.3 | 1.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.3 | 1.3 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.3 | 1.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.3 | 3.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.3 | 1.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.2 | 2.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.2 | 1.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.2 | 0.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.2 | 2.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.2 | 1.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.2 | 5.3 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.2 | 1.0 | GO:0005715 | late recombination nodule(GO:0005715) |
| 0.2 | 12.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.2 | 0.2 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.2 | 1.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.2 | 3.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.2 | 7.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
| 0.2 | 3.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.2 | 5.5 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.2 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.2 | 1.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.2 | 2.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.2 | 2.5 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.2 | 0.4 | GO:0044453 | nuclear membrane part(GO:0044453) |
| 0.2 | 1.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.2 | 1.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.2 | 0.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.2 | 1.6 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.2 | 0.6 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.2 | 2.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.2 | 4.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.2 | 3.3 | GO:0033179 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.2 | 1.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.2 | 0.8 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.2 | 1.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.2 | 4.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.2 | 19.9 | GO:0031514 | motile cilium(GO:0031514) |
| 0.2 | 3.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.2 | 0.9 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.2 | 1.9 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.2 | 1.5 | GO:0044754 | autolysosome(GO:0044754) |
| 0.2 | 0.9 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.2 | 0.5 | GO:0060187 | cell pole(GO:0060187) |
| 0.2 | 6.1 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.2 | 3.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.2 | 3.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.2 | 8.3 | GO:0016592 | mediator complex(GO:0016592) |
| 0.2 | 0.9 | GO:0070695 | FHF complex(GO:0070695) |
| 0.2 | 1.2 | GO:0042825 | TAP complex(GO:0042825) |
| 0.2 | 1.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.2 | 1.6 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.2 | 0.5 | GO:0031251 | PAN complex(GO:0031251) |
| 0.2 | 0.9 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.2 | 1.4 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.2 | 1.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.2 | 0.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.2 | 0.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.2 | 2.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.2 | 1.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.2 | 2.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.2 | 5.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.2 | 1.1 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.2 | 0.5 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.2 | 2.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.2 | 0.6 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.2 | 6.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.2 | 1.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.2 | 0.8 | GO:0044094 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 0.2 | 0.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.2 | 0.3 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.1 | 1.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.1 | 1.2 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 3.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.1 | 11.6 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.1 | 1.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.1 | 4.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 2.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 3.2 | GO:0000786 | nucleosome(GO:0000786) |
| 0.1 | 1.6 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 0.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 0.9 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.1 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.1 | 0.8 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.1 | 1.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 0.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.1 | 0.5 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.1 | 6.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.1 | 1.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.1 | 1.1 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.1 | 0.7 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 1.7 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 0.4 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.1 | 4.3 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.1 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.1 | 7.2 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.1 | 7.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 0.1 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.1 | 0.4 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.1 | 0.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 3.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 0.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.1 | 2.1 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.1 | 0.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.1 | 0.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 0.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
| 0.1 | 8.7 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 1.0 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.1 | 4.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 1.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 0.9 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.1 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 1.8 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 2.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.1 | 1.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 0.4 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.1 | 9.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.1 | 0.4 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.1 | 0.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 0.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.1 | 0.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.1 | 6.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 1.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.1 | 0.6 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.1 | 11.0 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.1 | 3.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 0.8 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.1 | 0.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 3.8 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.1 | 0.6 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.1 | 0.7 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.1 | 1.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 3.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.1 | 1.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.1 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.1 | 0.4 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.1 | 0.6 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.1 | 1.0 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 1.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.1 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 0.2 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
| 0.1 | 0.6 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.1 | 1.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 2.4 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 2.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 0.6 | GO:0032009 | early phagosome(GO:0032009) |
| 0.1 | 0.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 1.0 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.3 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.1 | 0.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.1 | 0.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 0.1 | 0.3 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 1.2 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 6.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 0.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.1 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
| 0.1 | 0.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 0.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
| 0.1 | 1.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 2.6 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 0.1 | 0.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.1 | 0.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.1 | 5.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.1 | 0.4 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.1 | 0.4 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.1 | 8.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 2.3 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 3.2 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.1 | 0.3 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.1 | 0.7 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.1 | 0.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.1 | 3.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.1 | 0.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.1 | 1.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 0.1 | GO:0071920 | cleavage body(GO:0071920) |
| 0.1 | 0.4 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 0.1 | 0.3 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.1 | 1.1 | GO:0031932 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
| 0.1 | 4.0 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 0.4 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.1 | 0.2 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.1 | 1.0 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 0.2 | GO:1990357 | terminal web(GO:1990357) |
| 0.1 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 2.1 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.1 | 0.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.1 | 0.5 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.1 | 0.2 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 0.8 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.1 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 0.1 | GO:1990742 | microvesicle(GO:1990742) |
| 0.0 | 0.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 0.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.0 | 1.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.0 | 0.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.0 | 0.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.0 | 3.9 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 2.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
| 0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.0 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.0 | 0.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.0 | 1.2 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.0 | 0.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.0 | 0.8 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.0 | 14.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.0 | 1.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.0 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.0 | 6.3 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.0 | GO:0019866 | organelle inner membrane(GO:0019866) |
| 0.0 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
| 0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 0.1 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.0 | 0.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.0 | 0.3 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
| 0.0 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.0 | 0.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.0 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
| 0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.0 | 0.3 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.0 | 2.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.2 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
| 0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.0 | GO:1990745 | EARP complex(GO:1990745) |
| 0.0 | 0.8 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.0 | 0.1 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.0 | 1.4 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 2.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 0.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.0 | 0.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.0 | 0.1 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.0 | 2.5 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.0 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.0 | 3.0 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 0.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.0 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.0 | 1.2 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 2.1 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 1.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
| 0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.0 | 0.9 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 1.9 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.0 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
| 0.0 | 0.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.0 | 0.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.0 | 1.6 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.0 | 0.0 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.0 | 2.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 0.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.0 | 0.1 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.0 | 0.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 0.9 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.0 | 7.9 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.0 | 9.9 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.0 | 0.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.1 | 12.3 | GO:0032567 | dGTPase activity(GO:0008832) triphosphoric monoester hydrolase activity(GO:0016793) guanyl deoxyribonucleotide binding(GO:0032560) dGTP binding(GO:0032567) |
| 2.3 | 7.0 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 2.1 | 6.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 1.9 | 7.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 1.8 | 1.8 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 1.6 | 4.7 | GO:0005292 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 1.3 | 6.7 | GO:0004803 | transposase activity(GO:0004803) |
| 1.2 | 3.5 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 1.1 | 5.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 1.1 | 3.4 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 1.1 | 4.5 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 1.1 | 7.4 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 1.0 | 3.1 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 1.0 | 4.0 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 1.0 | 3.9 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 1.0 | 1.0 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.9 | 2.8 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.9 | 5.6 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.9 | 2.8 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.9 | 2.8 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.9 | 13.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.9 | 4.4 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.8 | 11.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.8 | 2.5 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.8 | 2.5 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 0.8 | 4.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 0.8 | 2.4 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 0.8 | 4.0 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.8 | 2.4 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.8 | 3.1 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 0.7 | 3.0 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.7 | 4.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.7 | 2.2 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.7 | 2.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 0.7 | 2.1 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.7 | 5.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.7 | 2.1 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.7 | 2.8 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.7 | 2.0 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.7 | 2.0 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.7 | 5.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.7 | 4.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.7 | 2.0 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.6 | 0.6 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.6 | 1.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.6 | 4.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.6 | 1.8 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.6 | 4.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.6 | 1.2 | GO:0051870 | methotrexate binding(GO:0051870) |
| 0.6 | 19.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.6 | 3.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.6 | 2.4 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 0.6 | 0.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.6 | 1.7 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
| 0.6 | 2.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.6 | 2.2 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.6 | 1.7 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.6 | 4.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.6 | 11.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.5 | 2.7 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.5 | 1.1 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
| 0.5 | 2.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.5 | 4.6 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.5 | 6.0 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.5 | 1.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.5 | 4.9 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.5 | 2.0 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.5 | 3.3 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.5 | 0.5 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.5 | 6.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.5 | 1.4 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
| 0.5 | 3.7 | GO:0046979 | TAP2 binding(GO:0046979) |
| 0.5 | 1.4 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.5 | 2.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.5 | 1.8 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.5 | 1.4 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.5 | 4.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.5 | 2.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.5 | 2.7 | GO:0042806 | fucose binding(GO:0042806) |
| 0.4 | 2.7 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.4 | 4.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.4 | 3.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.4 | 1.8 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
| 0.4 | 1.8 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.4 | 1.3 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.4 | 3.9 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.4 | 1.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.4 | 1.7 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.4 | 5.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.4 | 2.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.4 | 3.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.4 | 0.4 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.4 | 3.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.4 | 1.7 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.4 | 3.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.4 | 1.2 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 0.4 | 1.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.4 | 3.3 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.4 | 0.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.4 | 2.9 | GO:0016803 | ether hydrolase activity(GO:0016803) |
| 0.4 | 1.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.4 | 1.6 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.4 | 1.2 | GO:0000406 | double-strand/single-strand DNA junction binding(GO:0000406) single guanine insertion binding(GO:0032142) dinucleotide repeat insertion binding(GO:0032181) |
| 0.4 | 1.2 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
| 0.4 | 0.4 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.4 | 2.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.4 | 2.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.4 | 0.4 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.4 | 2.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.4 | 5.5 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
| 0.4 | 1.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.4 | 4.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.4 | 3.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.4 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.4 | 2.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.4 | 3.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.4 | 1.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.4 | 1.8 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.4 | 1.1 | GO:0055103 | ligase regulator activity(GO:0055103) |
| 0.4 | 0.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.4 | 1.1 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
| 0.4 | 2.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.3 | 1.4 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.3 | 6.6 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.3 | 1.4 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.3 | 4.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.3 | 1.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.3 | 9.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.3 | 6.1 | GO:0015250 | water channel activity(GO:0015250) |
| 0.3 | 1.0 | GO:0090422 | thiamine pyrophosphate transporter activity(GO:0090422) |
| 0.3 | 2.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.3 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.3 | 2.3 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.3 | 2.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.3 | 1.0 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.3 | 1.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.3 | 1.0 | GO:0004040 | amidase activity(GO:0004040) |
| 0.3 | 1.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.3 | 1.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.3 | 0.9 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.3 | 2.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.3 | 0.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.3 | 1.6 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
| 0.3 | 1.3 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.3 | 1.2 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.3 | 0.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.3 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.3 | 0.9 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.3 | 2.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.3 | 1.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.3 | 0.9 | GO:0097259 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.3 | 0.9 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.3 | 1.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.3 | 2.1 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.3 | 1.5 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.3 | 0.9 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.3 | 4.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.3 | 0.9 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) V2 vasopressin receptor binding(GO:0031896) |
| 0.3 | 9.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.3 | 1.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.3 | 6.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.3 | 1.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.3 | 1.1 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.3 | 0.6 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.3 | 0.8 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.3 | 1.1 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 0.3 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.3 | 7.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.3 | 3.6 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.3 | 1.6 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.3 | 4.6 | GO:0015923 | mannosidase activity(GO:0015923) |
| 0.3 | 1.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.3 | 3.0 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.3 | 3.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.3 | 1.3 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.3 | 2.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.3 | 1.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
| 0.3 | 7.1 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.3 | 0.8 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.3 | 0.8 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.3 | 1.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
| 0.3 | 2.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.3 | 2.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.3 | 2.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.3 | 9.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.3 | 1.3 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.3 | 4.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.3 | 2.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.3 | 1.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.3 | 1.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.3 | 2.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.3 | 0.3 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
| 0.2 | 0.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.2 | 1.0 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.2 | 1.0 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.2 | 1.0 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.2 | 1.2 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.2 | 5.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.2 | 0.7 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.2 | 1.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.2 | 3.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.2 | 1.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.2 | 7.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.2 | 0.7 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.2 | 2.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.2 | 1.2 | GO:0033857 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.2 | 1.4 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.2 | 1.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.2 | 0.9 | GO:1904492 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
| 0.2 | 0.9 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.2 | 0.5 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
| 0.2 | 3.4 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.2 | 2.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.2 | 1.1 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.2 | 0.7 | GO:0061599 | nitrate reductase activity(GO:0008940) molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.2 | 2.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.2 | 3.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.2 | 0.9 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.2 | 0.9 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.2 | 0.7 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.2 | 0.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.2 | 0.6 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.2 | 1.7 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 0.2 | 1.9 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.2 | 1.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.2 | 0.8 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 0.2 | 1.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.2 | 1.7 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.2 | 2.3 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
| 0.2 | 2.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 0.8 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.2 | 4.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.2 | 0.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.2 | 0.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.2 | 0.8 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.2 | 0.6 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.2 | 1.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.2 | 3.0 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.2 | 0.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.2 | 0.2 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.2 | 0.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
| 0.2 | 0.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.2 | 0.6 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.2 | 2.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.2 | 6.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.2 | 0.6 | GO:0035730 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
| 0.2 | 2.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.2 | 0.6 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
| 0.2 | 0.6 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
| 0.2 | 0.2 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.2 | 1.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.2 | 0.6 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.2 | 0.6 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
| 0.2 | 0.6 | GO:0004556 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
| 0.2 | 3.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.2 | 3.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.2 | 1.0 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.2 | 2.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.2 | 0.8 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.2 | 0.8 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.2 | 0.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.2 | 1.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.2 | 1.3 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.2 | 0.9 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 0.2 | 0.2 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
| 0.2 | 0.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.2 | 2.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.2 | 0.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.2 | 0.6 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.2 | 7.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.2 | 1.6 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 0.2 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.2 | 3.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.2 | 1.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.2 | 1.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.2 | 1.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.2 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.2 | 0.5 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.2 | 2.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.2 | 2.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.2 | 0.5 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
| 0.2 | 0.5 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.2 | 1.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.2 | 0.7 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.2 | 0.7 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.2 | 2.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.2 | 5.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.2 | 0.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.2 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.2 | 6.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.2 | 0.5 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 0.2 | 0.5 | GO:0015403 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.2 | 2.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.2 | 2.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.2 | 3.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.2 | 1.5 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.2 | 4.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.2 | 1.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 3.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.2 | 1.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.2 | 2.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.2 | 1.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.2 | 1.0 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.2 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.2 | 0.6 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.2 | 0.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.2 | 1.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.2 | 0.5 | GO:0019777 | Atg12 transferase activity(GO:0019777) |
| 0.2 | 0.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.2 | 2.0 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.2 | 0.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.2 | 3.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.2 | 1.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.2 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.2 | 2.0 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.2 | 0.8 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.2 | 0.5 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.2 | 0.5 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.2 | 4.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.2 | 2.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.2 | 2.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 0.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.2 | 0.8 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
| 0.1 | 0.7 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.1 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 2.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.1 | 0.3 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.1 | 0.6 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.1 | 0.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.1 | 1.0 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.1 | 1.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.1 | 0.9 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.1 | 0.6 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.1 | 0.4 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 0.1 | 0.6 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.1 | 1.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.1 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
| 0.1 | 0.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.1 | 0.4 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.1 | 2.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 7.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.1 | 1.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 6.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.1 | 12.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.1 | 1.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 0.1 | 0.4 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.1 | 0.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 5.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.1 | 0.4 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.1 | 0.3 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.1 | 2.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.1 | 0.4 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 0.1 | 1.1 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.1 | 3.0 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 0.7 | GO:0031432 | titin binding(GO:0031432) |
| 0.1 | 0.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.1 | 1.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.1 | 5.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 3.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 0.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.1 | 0.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.1 | 0.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.1 | 2.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.1 | 1.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) tRNA-specific ribonuclease activity(GO:0004549) |
| 0.1 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 0.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.1 | 2.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 0.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 0.1 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.1 | 0.3 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 0.1 | 0.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.1 | 4.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.1 | 1.0 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.1 | 2.0 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 1.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.1 | 1.0 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 0.9 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.1 | 2.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.1 | 0.4 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.1 | 1.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.1 | 3.5 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.1 | 5.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 0.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.1 | 8.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 0.5 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 2.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 1.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.1 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.1 | 0.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 1.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.1 | 0.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.1 | 5.6 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.1 | 0.4 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.1 | 0.5 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.1 | 0.6 | GO:0008430 | selenium binding(GO:0008430) |
| 0.1 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.1 | 0.4 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.1 | 1.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.1 | 2.4 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.1 | 2.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 0.7 | GO:0019863 | IgE binding(GO:0019863) |
| 0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.1 | 0.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.1 | 0.2 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 0.1 | 0.2 | GO:0004146 | dihydrofolate reductase activity(GO:0004146) |
| 0.1 | 1.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.1 | 8.4 | GO:0042805 | actinin binding(GO:0042805) |
| 0.1 | 0.1 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.1 | 5.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 2.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 0.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.1 | 0.5 | GO:0031403 | lithium ion binding(GO:0031403) |
| 0.1 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.1 | 0.1 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.1 | 0.5 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.1 | 0.3 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.1 | 1.3 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.1 | 0.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
| 0.1 | 3.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 2.2 | GO:0001093 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) TFIIB-class transcription factor binding(GO:0001093) |
| 0.1 | 0.5 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.1 | 5.8 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.1 | 1.3 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.1 | 3.0 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
| 0.1 | 0.2 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.1 | 1.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.1 | 0.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.1 | 0.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.1 | 8.7 | GO:0031072 | heat shock protein binding(GO:0031072) |
| 0.1 | 0.6 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.1 | 0.4 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.1 | 5.2 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) |
| 0.1 | 0.7 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
| 0.1 | 2.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 0.4 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.1 | 0.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.1 | 0.5 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.1 | 0.2 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.1 | 1.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 6.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
| 0.1 | 1.0 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.1 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.1 | 0.3 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.1 | 0.4 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.1 | 0.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.1 | 0.3 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.1 | 0.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.1 | 3.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 0.4 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
| 0.1 | 2.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 1.5 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.1 | 0.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
| 0.1 | 1.1 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 0.4 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.1 | 0.7 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.1 | 2.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.1 | 0.5 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.1 | 0.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.1 | 0.6 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.1 | 0.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 0.3 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.1 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 0.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
| 0.1 | 0.6 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.1 | 0.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.1 | 0.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.1 | 0.9 | GO:0036122 | BMP binding(GO:0036122) |
| 0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
| 0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.1 | 0.6 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
| 0.1 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.1 | 0.6 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 0.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.1 | 1.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.1 | 0.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.1 | 2.9 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 0.3 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.1 | 4.1 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.1 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 0.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 0.6 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.1 | 0.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 0.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.1 | 0.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.1 | 0.4 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.1 | 3.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 1.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 0.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 2.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 0.3 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.1 | 3.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 0.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.1 | 1.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.1 | 2.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 0.8 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 0.1 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
| 0.1 | 0.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.1 | 0.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.1 | 0.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 0.3 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.1 | 1.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 0.2 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.1 | 1.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.1 | 1.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.1 | 0.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 0.5 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
| 0.1 | 0.3 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.1 | 0.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.1 | 0.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.1 | 0.8 | GO:0022821 | potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
| 0.1 | 0.3 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.1 | 0.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 1.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 0.8 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
| 0.1 | 0.5 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.1 | 0.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.1 | 0.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.1 | 0.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.1 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.1 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.1 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.1 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.1 | 6.8 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.1 | 0.7 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.1 | 0.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.1 | 0.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 0.2 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.1 | 3.8 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.1 | 0.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.1 | 1.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.1 | 2.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.1 | 0.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.1 | 0.2 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.1 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.1 | 0.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.1 | 0.7 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.1 | 0.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 0.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
| 0.1 | 0.1 | GO:0032404 | mismatch repair complex binding(GO:0032404) MutSalpha complex binding(GO:0032407) |
| 0.1 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
| 0.1 | 0.2 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.1 | 1.2 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 0.2 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.1 | 1.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 1.3 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 0.7 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.1 | 0.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 0.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 0.9 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.1 | 0.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.1 | 0.1 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
| 0.1 | 0.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 0.2 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 0.1 | 1.3 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.1 | 0.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.1 | 0.3 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.1 | 0.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.7 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.0 | 0.1 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
| 0.0 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.0 | 1.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.0 | 3.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 1.5 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
| 0.0 | 0.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.0 | 0.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 0.1 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
| 0.0 | 0.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.0 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.0 | 0.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.0 | 0.1 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.0 | 0.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.0 | 0.6 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
| 0.0 | 0.2 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.0 | 3.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
| 0.0 | 0.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.0 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
| 0.0 | 0.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 3.5 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.0 | 0.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 0.8 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.0 | 0.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
| 0.0 | 0.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.0 | 1.4 | GO:0034062 | RNA polymerase activity(GO:0034062) |
| 0.0 | 0.1 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.0 | 0.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.0 | 0.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.0 | 0.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.0 | 1.2 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 0.5 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.0 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.0 | 0.1 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.0 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.0 | 0.0 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.0 | 1.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.0 | 0.1 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.0 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.0 | 0.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.0 | 0.1 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.0 | 1.1 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.0 | 0.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.0 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.0 | 0.1 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.0 | 0.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
| 0.0 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.0 | 0.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
| 0.0 | 0.1 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 0.0 | 10.7 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 14.6 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 2.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 0.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.0 | 1.7 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.0 | 7.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.0 | 0.8 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
| 0.0 | 0.1 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.0 | 0.3 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 0.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.0 | 0.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.0 | 0.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.0 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
| 0.0 | 0.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.0 | 0.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.0 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.0 | 0.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.0 | 0.6 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 1.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 0.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 0.2 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.0 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
| 0.0 | 40.5 | GO:0003677 | DNA binding(GO:0003677) |
| 0.0 | 0.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.0 | 0.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.0 | 0.0 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
| 0.0 | 0.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.0 | 0.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.0 | 0.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.0 | 0.5 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.0 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.0 | 0.1 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
| 0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.0 | 0.1 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.0 | 0.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.0 | 0.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.0 | 0.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.0 | 0.0 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.0 | 1.1 | GO:0005525 | GTP binding(GO:0005525) |
| 0.0 | 0.0 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 0.0 | 0.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 1.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.7 | 0.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.5 | 2.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.4 | 8.4 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.3 | 5.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.3 | 6.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.3 | 0.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.3 | 10.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.3 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.2 | 2.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 17.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.2 | 4.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.2 | 12.1 | PID BMP PATHWAY | BMP receptor signaling |
| 0.2 | 0.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.2 | 7.7 | PID MYC PATHWAY | C-MYC pathway |
| 0.2 | 6.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.2 | 19.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.2 | 6.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.2 | 3.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.2 | 2.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.2 | 0.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 12.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 3.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.1 | 6.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 6.9 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 5.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 1.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 5.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 4.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 0.9 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.1 | 0.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.1 | 5.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.1 | 1.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 2.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.1 | 2.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 2.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.1 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 6.1 | PID E2F PATHWAY | E2F transcription factor network |
| 0.1 | 1.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 0.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.1 | 3.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 2.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 2.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.0 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 1.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.0 | 2.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 1.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 4.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.0 | 0.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.0 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.0 | 2.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.0 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.0 | 4.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 1.9 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.0 | 0.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.0 | 0.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.0 | 0.5 | ST ADRENERGIC | Adrenergic Pathway |
| 0.0 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 0.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 1.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.0 | 0.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.0 | 0.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.0 | 0.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.0 | 0.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 1.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 0.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 1.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.6 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.6 | 7.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.6 | 1.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.5 | 7.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.4 | 4.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.4 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.4 | 7.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.3 | 1.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.3 | 19.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.3 | 0.7 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
| 0.3 | 1.0 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.3 | 6.6 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.3 | 6.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.3 | 8.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.3 | 3.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.3 | 4.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.3 | 6.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.3 | 5.9 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.3 | 6.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.3 | 6.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.3 | 0.8 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.2 | 2.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.2 | 14.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.2 | 6.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.2 | 7.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.2 | 4.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.2 | 3.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.2 | 6.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.2 | 2.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.2 | 3.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.2 | 4.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.2 | 5.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.2 | 4.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.2 | 4.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 16.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.2 | 0.3 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
| 0.2 | 1.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 2.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.2 | 7.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.2 | 1.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.2 | 0.3 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
| 0.2 | 2.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 3.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.1 | 4.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.1 | 1.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.1 | 1.0 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
| 0.1 | 4.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.1 | 0.4 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.1 | 0.4 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.1 | 2.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.1 | 10.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.1 | 2.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 3.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 0.7 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.1 | 1.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.1 | 2.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 8.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 1.0 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.1 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 1.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 3.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.1 | 1.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 2.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.1 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 0.1 | 2.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.1 | 0.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.1 | 1.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.1 | 2.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.1 | 1.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.1 | 4.8 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.1 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.1 | 0.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.1 | 0.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.1 | 1.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.1 | 2.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 8.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 2.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 2.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.1 | 1.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.1 | 1.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 2.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 2.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.1 | 0.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.1 | 0.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 0.1 | 0.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.1 | 1.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 2.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.1 | 31.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.1 | 2.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 0.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.1 | 3.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 0.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.1 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 0.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.1 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.1 | 2.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.1 | 2.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 0.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 1.1 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.1 | 3.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 1.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 1.4 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.1 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.1 | 1.4 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
| 0.1 | 0.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.1 | 1.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.1 | 1.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 1.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 1.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 1.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.0 | 0.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.0 | 0.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.0 | 0.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.0 | 0.5 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 1.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 1.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 0.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.0 | 0.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
| 0.0 | 1.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.0 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.0 | 2.0 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
| 0.0 | 0.6 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
| 0.0 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
| 0.0 | 2.1 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
| 0.0 | 1.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.0 | 1.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 0.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.0 | 0.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 0.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.0 | 1.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 1.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.0 | 0.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 0.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 0.3 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |